Aenova Holding GmbH

The Aenova Group is a leading global contract manufacturer and development service provider for the pharmaceutical and healthcare industries. As a full-service provider, Aenova develops, produces and packages all common dosage forms, product groups and active ingredient classes of pharmaceuticals and food supplements for human and animal health: solid, semi-solid and liquid, sterile and non-sterile, high and low dose, OEB 1-5, and fill&finish of biologics/vaccines up to BSL-2. Around 4,200 employees at 16 locations worldwide contribute to Aenova's success.
Aenova is expanding its development and production portfolio, particularly in the area of bioavailability of active pharmaceutical ingredients and with differentiated technologies for complex therapeutic systems, e.g. intelligently encapsulated mini tablet systems or multi-unit pellet systems (MUPS), hot melt extrusion, dry powder inhaler (DPI) platform for micro-dosed capsule filling, co-precipitation, particle sizing and lipid-based soft capsule formulations.